AAMU
CDLX icon

Amundi Asset Management US’s Cardlytics CDLX Stock Holding History

Amundi Asset Management US’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$168K Buy
+153
New +$202K ﹤0.01% 1475
2020
Q3 		– Sell
-260
Closed -$182K – 1603
2020
Q2 		$182K Hold
260
– – ﹤0.01% 1395
2020
Q1 		$91K Buy
+260
New +$184K ﹤0.01% 1443

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Amundi Asset Management US's CDLX Position: Q1 2021 in Review

Amundi Asset Management US opened a new position in Cardlytics (CDLX) in Q1 2021: 153 shares worth $168K. The stake represents ﹤0.01% of the portfolio and ranks #1475 among its holdings. This is a return to the name: Amundi Asset Management US previously reported a position in CDLX as recently as Q2 2020.

Amundi Asset Management US first reported a position in CDLX in Q1 2020 and has held it in 3 quarters since. The position peaked at $182K in Q2 2020. 204 funds tracked by Wall St. Rank hold CDLX as of Q1 2021.

  • Amundi Asset Management US held 153 shares of Cardlytics worth $168K as of Q1 2021.
  • Cardlytics was a new Amundi Asset Management US position in Q1 2021.
  • Cardlytics made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1475 holding.
  • Amundi Asset Management US first reported a position in Cardlytics in Q1 2020 and has held it in 3 quarters since.
  • Amundi Asset Management US's Cardlytics position peaked at $182K in Q2 2020.
  • 204 funds tracked by Wall St. Rank held Cardlytics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.